Source: Eur Respir J, 52 (2) 1801312; 10.1183/13993003.01312-2018
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Wim Wuyts, Vincent Cottin. Idiopathic pulmonary fibrosis: time for greater expectations?. Eur Respir J, 52 (2) 1801312; 10.1183/13993003.01312-2018

Member's Comments

No comment yet.

Related content which might interest you: Communicating with patients with idiopathic pulmonary fibrosis: can we do it better? Source: ERJ Open Res, 8 (1) 00422-2021; 10.1183/23120541.00422-2021 Year: 2022 Severe idiopathic pulmonary fibrosis: what can be done? Source: Eur Respir Rev, 26 (145) 170047; 10.1183/16000617.0047-2017 Year: 2017 Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence? Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Idiopathic pulmonary fibrosis (IPF): the patient journey Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 The lived experience of idiopatic pulmonary fibrosis: A qualitative study Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences Year: 2016 The therapy of idiopathic pulmonary fibrosis: what is next? Source: Eur Respir Rev, 28 (153) 190021; 10.1183/16000617.0021-2019 Year: 2019 A global registry for idiopathic pulmonary fibrosis: the time is now Source: Eur Respir J 2014; 44: 273-276 Year: 2014 Idiopathic pulmonary fibrosis: a treatable disease? Source: Eur Respir J 2003 Dec 01;22(6):872-873 Year: 2003 Idiopathic pulmonary fibrosis: securing a confident diagnosis for every patient Source: Eur Respir J 2016; 47: 1057-1059 Year: 2016 Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation Source: Eur Respir J 2012; 40: 794-795 Year: 2012 Idiopathic pulmonary fibrosis: another step in understanding the burden of this disease Source: Eur Respir J 2016; 48: 26-28 Year: 2016 Idiopathic pulmonary fibrosis: Relationship between patient survival and distance-saturation product Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Idiopathic pulmonary fibrosis: tracking the true occurrence is challenging Source: Eur Respir J 2015; 46: 604-606 Year: 2015 Exercise training in idiopathic pulmonary fibrosis: is it of benefit? Source: Breathe 2016; 12: 130-138 Year: 2016 Idiopathic pulmonary fibrosis: present understanding and future options Source: Eur Respir Rev 2011; 20: 132-133 Year: 2011 Idiopathic pulmonary fibrosis: does smoking status influence outcome? Source: Eur Respir J 2006; 28: Suppl. 50, 830s Year: 2006 Home spirometry for idiopathic pulmonary fibrosis: ready for prime time? Source: Eur Respir J, 50 (1) 1701403; 10.1183/13993003.01403-2017 Year: 2017 Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Idiopathic pulmonary fibrosis: approaches to diagnostic Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002